+7 (701) 759 90 19
USD 429.59 EUR 507.3
RUB 5.62 CNY 64.1
News

Kazakhstani COVID-19 vaccine enters clinical trials

17 September 2020 17:29
Share in:
Kazakhstani COVID-19 vaccine enters clinical trials

NUR-SULTAN. KAZINFORM – Clinical trials of Kazakhstani QazCovid-in vaccine against the COVID-19 virus developed by the Scientific Research Institute for Biological Safety Problems have kicked off in Kazakhstan, Kazinform cites the Telegram channel of the Ministry of Education and Science.

Related news
Almaty city sees gradual rise in new daily COVID-19 cases Canadians urged to avoid large in-person gatherings as COVID-19 cases spike COVID-19: Three foreigners among 4 new daily cases in Aktobe rgn

It is informed that adult volunteers aged 18-50 years old will be involved in the clinical trials. Phase 1 trials will define the vaccine’s safety on 44 volunteers free of COVID-19 and antibodies. The 2nd phase is set to assess immunogenicity with the involvement of 22 volunteers.

A total of 688 applications have been submitted by citizens to take part in the clinical trials.

It is said that the vaccine’s clinical trials will be conducted at the Health Ministry’s National Scientific Center of Phthisiopulmonology and Сentre for Clinical Medicine and Resеarch LLP.



Share in:

Author:

Adlet Seilkhanov

+7
Send
Employees online
Editor
Nurmaganbetova Zhanna
Nurmaganbetova Zhanna
954-048
Editor
Kudrenok Tatyana
Kudrenok Tatyana
954-048
Editor
Seilkhanov Adlet
Seilkhanov Adlet
954-048

Archive